MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesicare 10mg tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesicare 10mg tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesicare 10mg tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesicare 5mg tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesicare 5mg tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesicare 5mg tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Vesomni 6mg/0.4mg modified-release tablets (Astellas Pharma Ltd).

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from VFEND 200mg tablets (Pfizer Ltd).

Stability Notes

Protect from light and moisture.

Provenance

This compatibility recommendation is derived from VFEND 50mg tablets (Pfizer Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.